These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38861920)

  • 1. [Pharmacogenetics in primary care: a tool to prevent adverse reactions to drugs].
    Capilla Díaz S; Gamero de Luna EJ
    Semergen; 2024 Jun; 50(6):102273. PubMed ID: 38861920
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic literacy series: clinical application of pharmacogenetics for adverse reactions to antiepileptic drugs.
    Zhang Z; Wu Y; Tan NC; Jiang Y
    Epileptic Disord; 2019 Aug; 21(4):330-336. PubMed ID: 31403464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of adverse drug reactions that may be related to pharmacogenetics in a public hospital in the South of Brazil.
    Camargo AC; Matte U; Botton MR
    Expert Opin Drug Saf; 2023; 22(7):621-627. PubMed ID: 36794346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The contribution of pharmacogenetics to pharmacovigilance.
    Bondon-Guitton E; Despas F; Becquemont L
    Therapie; 2016 Apr; 71(2):223-8. PubMed ID: 27080842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Web-Based Pharmacogenomics Search Tool for Precision Medicine in Perioperative Care.
    Zarei S; Costas Y; Orozco G; Zaydlin M; Mirtar A; Abouali M; Diaz-Marty C; Akhlaghipour G; Fernandez Altamirano P; Gonzalez Cardona AR; Reiley LE; Mirzakhani H
    J Pers Med; 2020 Jul; 10(3):. PubMed ID: 32708157
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of pharmacogenetics on the diversity of response to statins associated with adverse drug reactions.
    Sainz de Medrano Sainz JI; Brunet Serra M
    Adv Lab Med; 2023 Dec; 4(4):341-352. PubMed ID: 38106499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study.
    Swen JJ; van der Wouden CH; Manson LE; Abdullah-Koolmees H; Blagec K; Blagus T; Böhringer S; Cambon-Thomsen A; Cecchin E; Cheung KC; Deneer VH; Dupui M; Ingelman-Sundberg M; Jonsson S; Joefield-Roka C; Just KS; Karlsson MO; Konta L; Koopmann R; Kriek M; Lehr T; Mitropoulou C; Rial-Sebbag E; Rollinson V; Roncato R; Samwald M; Schaeffeler E; Skokou M; Schwab M; Steinberger D; Stingl JC; Tremmel R; Turner RM; van Rhenen MH; Dávila Fajardo CL; Dolžan V; Patrinos GP; Pirmohamed M; Sunder-Plassmann G; Toffoli G; Guchelaar HJ;
    Lancet; 2023 Feb; 401(10374):347-356. PubMed ID: 36739136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenomics and adverse drug reactions: Primetime and not ready for primetime tests.
    Khan DA
    J Allergy Clin Immunol; 2016 Oct; 138(4):943-955. PubMed ID: 27720019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics of Adverse Drug Reactions.
    Osanlou O; Pirmohamed M; Daly AK
    Adv Pharmacol; 2018; 83():155-190. PubMed ID: 29801574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nurse empowerment through Pharmacogenetics.
    Moraes JC; Nunes FDD; Coeli-Lacchini FB; Miyazaki AHL; Flória-Santos M; Lacchini R
    Rev Lat Am Enfermagem; 2020; 28():e3265. PubMed ID: 32813781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetics of adverse reactions to antiepileptic drugs.
    Fricke-Galindo I; Jung-Cook H; LLerena A; López-López M
    Neurologia (Engl Ed); 2018 Apr; 33(3):165-176. PubMed ID: 25976948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetic aspects of drug-induced torsade de pointes: potential tool for improving clinical drug development and prescribing.
    Shah RR
    Drug Saf; 2004; 27(3):145-72. PubMed ID: 14756578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of pharmacogenetics of adverse drug reactions in elderly people.
    Cardelli M; Marchegiani F; Corsonello A; Lattanzio F; Provinciali M
    Drug Saf; 2012 Jan; 35 Suppl 1():3-20. PubMed ID: 23446782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacogenetics and prediction of side effects of drugs].
    Harrak M; Khabbal Y; Amarti A; El Hassouni M; Ouldim K
    Ann Biol Clin (Paris); 2014; 72(4):405-12. PubMed ID: 25119798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics of antiepileptic drug-induced hypersensitivity.
    Bloch KM; Sills GJ; Pirmohamed M; Alfirevic A
    Pharmacogenomics; 2014 Apr; 15(6):857-68. PubMed ID: 24897291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics of selective serotonin reuptake inhibitors and associated adverse drug reactions.
    Thomas KL; Ellingrod VL
    Pharmacotherapy; 2009 Jul; 29(7):822-31. PubMed ID: 19558256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotype-guided drug prescribing vs. usual care reduced clinically relevant adverse drug reactions at 12 wk.
    Holbrook AM
    Ann Intern Med; 2023 Jun; 176(6):JC70. PubMed ID: 37276599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetics for severe adverse drug reactions induced by molecular-targeted therapy.
    Udagawa C; Zembutsu H
    Cancer Sci; 2020 Oct; 111(10):3445-3457. PubMed ID: 32780457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Utilization of Genomic Biomarkers for Post-marketing Safety of Drugs].
    Kaniwa N
    Yakugaku Zasshi; 2015; 135(5):671-9. PubMed ID: 25948300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining the opportunity for pharmacogenetic intervention in primary care.
    Grice GR; Seaton TL; Woodland AM; McLeod HL
    Pharmacogenomics; 2006 Jan; 7(1):61-5. PubMed ID: 16354125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.